Florbetaben F 18
Florbetaben F 18 is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Neuraceq. Available dosage form: injection, solution.
Drug Details
- Generic Name
- Florbetaben F 18
- Brand Names
- Neuraceq
- Application Number
- NDA204677
- Sponsor
- Lantheus Biosciences Ltd., a Lantheus company
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- FLORBETABEN F-18
Indications and Usage
1 INDICATIONS AND USAGE NEURACEQ is indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer’s disease (AD) and other causes of cognitive decline Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information of the therapeutic products NEURACEQ is a radioactive diagnostic drug indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer’s disease (AD) and other causes of cognitive decline Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information of the therapeutic products (1)